PharmexecMike retweeted
🔸Read about 2023 #EmergingPharmaLeader Justin To, Chief Operating Officer, Skeletal Dysplasias and Gene Therapy, @BridgeBioPharma ! 🔸
The recipe for cross-functional collaboration in #drugdevelopment🖋️Mike Hollan
➡️pharmexec.com/view/justin-to…
#GeneTherapy #pharmaceutical
PharmexecMike retweeted
🔸Congratulations to our 2023 Emerging Pharma Leaders🔸
Natasha Hernday of @SeagenGlobal
Simon Holland of @organonbiosim
Justin To of @BridgeBioPharma
Frank Watanabe of @ArcutisBio
Hanadie Yousef of Juvena Therapeutics
Read their profiles here: pharmexec.com/journals/pharm…
PharmexecMike retweeted
🚨Our July issue is LIVE🚨
An insightful discussion with @OtsukaUS' Christine Sakdalan🔷the changing role of #biopharma CFOs🔷Rethinking commission-based deals with independent contractors🔷and so much more waiting right here➡️ow.ly/ra7450JSKKN
#pharma #lifesciences
PharmexecMike retweeted
🚨Our June issue is LIVE🚨
The impact of war on drug #supplychain ▪️What makes #hub programs successful?▪️Counting down to 2023 #DSCSA #compliance ▪️and so much more right here➡️pharmaceuticalcommerce.com/v…
#pharma #lifesciences #pharmaceutical #manufacturing
PharmexecMike retweeted
🚨New Podcast Alert🚨
David Sanders, VP of government affairs & policy, @Coherus_Bio , speaks about the firm’s goal of expanding #patientaccess to cost-effective medication, his role with @samscoalition, and much more!
🎙️ow.ly/HrXb50J7ppH
#pharma #lifesciences #supplychain
PharmexecMike retweeted
🚨New Podcast Alert🚨
In episode 108, the rest of the PharmExec editorial staff join @PharmExecElaine Quilici and @mschmalfuhs to give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders
🎙️ow.ly/OIOK50J6iQq
#pharma







